MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer

This study is ongoing, but not recruiting participants.

Study NCT00326456 Information provided by National Cancer Institute, Naples

First Received on May 15, 2006. Last Updated on July 12, 2012 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Ovarian Cancer

Additional conditions recognized in this trial

Ovarian Neoplasms

More general conditions related to this trial

Interventions listed in this trial

liposomal doxorubicin
carboplatin
paclitaxel

Additional drug interventions recognized in this trial

Doxorubicin

More general drug interventions related to this trial

Sponsors listed in this trial